[Recent progress in neuroprotection of humanin against Alzheimer's disease-relevant neurotoxicity].
Cui. Ai-Ling AL; Zhao. Li L; Li. Ling-Min LM; Qiao. Jian-Tian JT; Zhang. Ce C
Key Findings
- Humanin is a 24‑amino‑acid peptide encoded by a gene found in normal‑looking brain tissue.
- It specifically protects neurons from Alzheimer’s‑related toxic insults such as beta‑amyloid, APP antibodies, and related genes.
- The protection involves forming a homodimer that interferes with beta‑amyloid activity, but it does not guard against other toxic challenges like Fas signaling or etoposide.
Practical Outcomes
- Humanin looks promising as a targeted anti‑Alzheimer’s agent, but current data are limited to laboratory studies. Biohackers should view it as a research candidate rather than a ready‑to‑use supplement, and await human safety and dosing studies before considering it in protocols.
Summary
Humanin is a tiny protein that can shield brain cells from damage caused by Alzheimer's‑related factors like beta‑amyloid, but it doesn't protect against other kinds of cell stress. The research is still early‑stage and done in lab models, so it doesn’t give clear dosing or safety info for everyday use.
Abstract
Alzheimer's disease (AD) is the leading cause of dementia for aging people, and far from control due to its obscure mechanism. Humanin, a 24-aa peptide encoded by a newly identified gene cloned from an apparently normal region of AD brain, can specifically attenuate AD-related neurotoxicity. It protects neurons from insults of various AD genes, anti-APP antibodies and Abeta by forming a homodimer outside and interfering directly or indirectly with the activity of Abeta. Humanin seems, however, not to inhibit other toxic insults to neurons, such as Fas or etoposide, an agent against carcinomatous cells in clinical therapy. So Humanin rescues neurons from various AD-related toxicity specifically with efficiency.
Study Information
pubmed
2006